Posted by ABMN Staff on May 11th, 2024
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Equities research analysts at B. Riley lowered their Q2 2024 earnings per share (EPS) estimates for shares of X4 Pharmaceuticals in a report released on Tuesday,...
More of this article »